Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CRGX is expected to report earnings to fall 26.55% to -129 cents per share on August 12
Q2'25
Est.
$-1.30
Q1'25
Missed
by $0.60
Q4'24
Beat
by $0.73
Q3'24
Beat
by $0.73
Q2'24
Beat
by $0.39
The last earnings report on May 14 showed earnings per share of -176 cents, missing the estimate of -116 cents. With 1.01M shares outstanding, the current market capitalization sits at 207.47M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRGX showed earnings on May 14, 2025. You can read more about the earnings report here.